Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
NSE faces a stayed Rs 856.99 crore compensation claim with 18% annual interest sought, while its Rs 35.5 crore CCI penalty recovery remains stayed.
NSE options generated 60.22% of Fiscal 2026 operating revenue, while transaction charges fell 4.24% after SEBI derivatives measures reduced average daily trading volumes.
NSE paid Rs 1,491.207 crore to SEBI on July 31, 2026 for two co-location matters, while one court closure and one settlement order remain pending.
NSE options generated Rs 9,998 crore, or 60.2%, of Fiscal 2026 operating revenue of Rs 16,601 crore, underscoring transaction-fee concentration.
FSSAI-AYUSH dual compliance raises nutraceutical entry barriers through licensing, GMP and claim requirements as India’s Ayurvedic products market is projected to grow 19.3% annually to 2028.
Himalaya's top 10 suppliers accounted for 94.30% of fiscal 2026 purchases, while its top 10 customers generated 81.24% of revenue without long-term agreements.
Himalaya Nutraveds had Rs 5.32 crore in borrowings on August 14, 2026, including Rs 4.82 crore, or 90.6%, in ICICI cash credit.
The Company’s pre-IPO gifts, rights issue and bonus issue left three promoters with 82.70% of its 63,06,720 pre-issue Equity Shares.
Himalaya Nutravedics plans a Rs 7.5 crore digital buildout, with Rs 4.41 crore, or 58.8%, allocated to marketplace and quick-commerce promotions.
Himalaya Nutravedics projects Rs 28.4466 crore of net working capital by March 2028, driven by 90 inventory days, 94 receivable days and 18 payable days.
Himalaya Nutravedics reported FY2026 profit of Rs 7.40 crore but used Rs 3.83 crore in operating cash as working-capital balances expanded.
Himalaya Nutradetics received approximately 90% of contract-manufacturing revenue from Kerala, while the state contributed Rs 21.2472 crore, or 49.33%, of fiscal 2026 sales.
Himalaya Nutravedics India Limited expects to remove its opposed corporate trademark from packaging within six months, covering more than 100 products across 17 states.
Himalaya Nutradetics reported Rs 22.0254 crore of own-brand revenue in FY26, representing 51.14% of total revenue and exceeding contract manufacturing sales.
Anand Seamless plans a 25% rise in finned-tube capacity to 4,50,000 metres at Kadi, backed by Rs 13.20 crore of IPO net proceeds.
The Company’s December 2025 80-for-1 bonus issue created 83.21 lakh shares, lifting pre-IPO paid-up equity from 1.04 lakh to 84.25 lakh shares.
